» Articles » PMID: 2127168

A Comparative Evaluation of Iron Clearance Models

Overview
Specialty Science
Date 1990 Jan 1
PMID 2127168
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

A comparative study of the non-iron-overloaded, bile duct-cannulated rat and of the Cebus monkey as iron-clearance models is presented. The ability of desferrioxamine, desferrithiocin, and a pyridoxal isonicotinoyl hydrazone (PIH) analogue to clear the metal from these two animals is evaluated. Data suggest that although rodents represent a viable first-line animal screen, there is no strict correspondence between the effectiveness of a chelator in rodents and that in primates. Rodent data should be interpreted carefully as it relates to potential human trials. Iron-loading response, the similarity between multiple human and Cebus serum and hematological values, and the ability to easily observe changes in behavioral patterns clearly render the Cebus monkey the best preclinical screen.

Citing Articles

Is Chelation Therapy a Potential Treatment for Parkinson's Disease?.

Ward R, Dexter D, Martin-Bastida A, Crichton R Int J Mol Sci. 2021; 22(7).

PMID: 33805195 PMC: 8036775. DOI: 10.3390/ijms22073338.


The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary-Ironing out the Brain.

Crichton R, Ward R, Hider R Pharmaceuticals (Basel). 2019; 12(3).

PMID: 31533229 PMC: 6789569. DOI: 10.3390/ph12030138.


Metabolically programmed iron chelators.

Bergeron R, Bharti N, McManis J, Wiegand J Bioorg Med Chem. 2015; 23(17):5954-71.

PMID: 26231739 PMC: 4608554. DOI: 10.1016/j.bmc.2015.06.059.


Desferrithiocin: a search for clinically effective iron chelators.

Bergeron R, Wiegand J, McManis J, Bharti N J Med Chem. 2014; 57(22):9259-91.

PMID: 25207964 PMC: 4255733. DOI: 10.1021/jm500828f.


Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.

Bergeron R, Wiegand J, Bharti N, McManis J J Med Chem. 2012; 55(16):7090-103.

PMID: 22889170 PMC: 3583384. DOI: 10.1021/jm300509y.